Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
The Perth Blood Institute Limited
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • Who we are
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
      • Thrombosis Australia Advisory Panel
    • Work with us
  • Our clinical trials
    • Clinical trials
    • Collaborations
    • Participate in a clinical trial
    • Useful links
  • Our research
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Information on blood disorders
      • Haemophilia
      • TTP
      • Thrombophilia
      • von Willebrand Disease
    • For patients and families
  • Personal stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Partner with us
    • Leave a gift in your will
    • Other ways to help
  • News and Events
    • Latest news & info
    • Past news items
    • Significant days
    • Media
    • Upcoming events
    • Past events
    • Publications
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)
  • What we do
  1. Who we are
  2. What we do

What we do

PBI’s work is underpinned by:

  1. PBI research
  2. PBI clinical trials
  3. Community education

PBI research 

The PBI Research division's mission is to improve patient outcomes through the development of targeted therapies. It does this by collecting validated clinical data and bio-banked biological material from patients with common and rare fatal blood diseases, to better understand the molecular basis of diseases. This improved knowledge allows PBI to develop new diagnostic tests and targeted therapies.

The fundamental (experimental) research conducted by PBI’s research scientists is vital in translating novel findings into new treatments and information to benefit clinical phase studies. Examples of fundamental research include molecular studies, cellular assays and studies on the properties of drugs and patient samples.

PBI’s Research Division has two main units:

  1. Translational molecular research team
  2. Platelet research team

Translational molecular research team

The Translational Molecular Research Team focuses on understanding genetic mechanisms underlying the complex coagulation system, and aims to develop novel biomarkers in the form of liquid biopsies for complex blood disorders as well as difficult to drug or undruggable cancers.  This team’s research is built on the group’s understanding of microRNAs and the important role they play in our pathways of interest. Ultimately, we aim to develop precision-based, next-generation therapeutics to address current unmet medical need in blood disorders, and related diseases.

Platelet research team

The Platelet Research Team aims to understand the contributory role of platelets in various diseases. Apart from their main role in wound healing and blood clotting processes, platelets are integral to a multitude of biological functions, including inflammation and innate immunity. The principle aim of the Platelet Research Team is to study and characterise the changes involved in haemostasis and platelet function during disease. The goal is to apply our understanding of the fundamental research to discover new strategies or improve current treatments for blood disorders, cancer and dementia.

PBI clinical trials

The PBI Clinical Trials Division delivers numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers. It provides opportunities for patients to participate in PBI studies into new treatments and interventions to prevent, diagnose or manage blood disorders.

Clinical Trials are vital for the development of new medical treatments. They play a key role in determining if new medicines/interventions are effective, safe and/or superior to the current gold standard of care treatments available on the market today. Clinical trials are the final step in a long process that begins with research in a laboratory.

Community education

PBI regularly conducts programs to support and increase community understanding of blood disorders. These include:

  • Professional education programs are aimed at ensuring health professionals have access to the latest information on blood disorders; and
  • Community awareness programs aim to provide support to patients with a blood disorder, and their families.

Relationship between our teams

PBI fosters a culture of continuous sharing of information between our Research and Clinical Trials Teams, based on the exchange of information and findings. Outcomes from each team provide education and guidance for future research. In particular, the results from the Clinical Trials Team investigations – whether they are successful outcomes for medical trials, or less desirable outcomes – steer the focus of our Research Team.

Patient care

An integral part of PBI’s high standard of care is the ability to involve people in state-of-the-art clinical trials and translational research.

Clinical trials offer people with blood disorders the most up-to-date treatment options which have been developed through extensive clinical research.

For further information on how to get involved in PBI’s clinical trials or research, please visit Participate in a clinical trial or Participate in a research project.

Published: 21st October, 2019

Updated: 27th January, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • COVAXI-2 (Haematological diseases - RECRUITMENT: OPEN)

    COVAXI-2 (Haematological diseases - RECRUITMENT: OPEN)

    This is an observational Cohort study to assess the immune response to the SARS-CoV-2 vaccination and the prevalence of clotting related antibodies in haematology and other immunosuppressed patients.

  • COVAXI Clinical Trial

    COVAXI Clinical Trial

    Perth Blood Institute (PBI) is pleased to announce the commencement of a clinical trial to assess the immune response to the SARS-CoV-2 vaccination – the COVAXI trial.

  • Long COVID

    Long COVID

    Here we discuss some of the latest research relating to Long COVID, also known as PASC (post-acute sequelae of COVID).

  • American Society of Hematology conference 2022

    American Society of Hematology conference 2022

    The annual American Society of Hematology Meeting and Exposition was held in New Orleans, December 10-13. Abstracts presented at the conference represent important, novel research in the field and are considered the best of the thousands of abstracts submitted.

Most read

  • What is thrombosis?

    What is thrombosis?

    Click here to learn more about thrombosis.

  • What are DVT & PE?

    What are DVT & PE?

    Click here to learn more about DVT and PE.

  • Antiphospholipid Antibody Syndrome

    Antiphospholipid Antibody Syndrome

    Click here for information about antiphospholipid antibody syndrome and how it can lead to thrombosis.

  • Contraception and Thrombosis

    Contraception and Thrombosis

    Click here to learn more about how certain contraceptives can increase your risk of dangerous blood clots.

  • Work and Thrombosis

    Work and Thrombosis

    Click here to learn more about how work can increase your risk of thrombosis, and how to prevent it.

  • Inherited Thrombophilias

    Inherited Thrombophilias

    Click here for information about genetic conditions that can increase the chances of thrombosis.

  • Investigators

    Investigators

  • Participate in a clinical trial

    Participate in a clinical trial

    PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers.

  • COVID-19 and Thrombosis

    COVID-19 and Thrombosis

    Click here for frequently asked questions and links to resources regarding COVID-19 and thrombosis.

  • Pregnancy and Thrombosis

    Pregnancy and Thrombosis

    Click here to learn about how pregnancy can increase your risk of thrombosis.

Tag cloud

Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA
Donate today

Donate today

Please help to make blood disorders a thing of the past. Every amount is vital to our research, no matter how large or small. Read more

Donate Fundraise

Published: 18th February, 2020

Updated: 8th February, 2023

Author:

Elie's story

Elie's story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor. Read more

Published: 9th July, 2020

Updated: 28th March, 2022

Author: Jake Harfield

Purchase a Entertainment™ Digital Membership and support PBI

Purchase a Entertainment™ Digital Membership and support PBI

Gain access to over 20,000 local & national offers and support Perth Blood Institute at the same time. Read more

Published: 2nd August, 2021

Updated: 25th January, 2022

Author: Bec Morgan

Perth Blood Institute benefits from family ties

Perth Blood Institute benefits from family ties

The family of a Perth mum who has a blood condition so rare that she’s almost one in a million is rallying behind her – and gaining support from numerous work colleagues. Read more

Published: 21st February, 2022

Updated: 4th April, 2022

Author: Felicity Barnes

Celebrating World Health Day

Celebrating World Health Day

In recogntion of WHD 2022, find out how our patients look after their physical and mental wellbeing while living with a blood disorder. Read more

Published: 28th March, 2022

Updated: 8th February, 2023

Author: Felicity Barnes

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020